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bition by dopamine (1   M ) in both experimental groups 
throughout the study.  Conclusions: In the nephrotic syn-
drome the jejunal Na + ,K + -ATPase activity may respond 
in a compensatory way to changes in extracellular vol-
ume, through dopamine-independent mechanisms. 
 Copyright © 2005 S. Karger AG, Basel 
 Introduction 
 In the mammalian small intestine the driving force for 
fl uid absorption is the active transport of sodium and 
chloride, which may be electrically silent  [1] or which may 
involve electrogenic sodium transport  [2] . The primary 
mechanism responsible for the transepithelial sodium 
transport in the small intestine is the basolateral Na + ,K + -
ATPase  [3] of both absorptive and secretory cell types  [4, 
5] . The transepithelial transport of other solutes and elec-
trolytes such as glucose, amino acids, chloride and bicar-
bonate is indirectly coupled to sodium transport  [4] . 
 The basal activity of the intestinal Na + ,K + -ATPase can 
be infl uenced or modulated by different factors including 
dopamine. In the intestine, the dopaminergic system has 
been characterized as a local non-neuronal system consti-
tuted by epithelial cells of intestinal mucosa rich in aro-
matic  L -amino acid decarboxylase (AADC), the enzyme 
responsible for the synthesis of dopamine from circulat-
ing or luminal  L -3,4-dihydroxyphenylalanine ( L -Dopa) 
 [6] . Dopamine is particularly abundant in the mucosal 
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 Abstract 
 Background: The occurrence of complementary func-
tions in sodium transport between the intestine and the 
kidney was suggested to occur when the renal function 
is immature or compromised and jejunal dopamine has 
been implicated in this renal-intestinal cross-talk. The je-
junal sodium transport was not previously evaluated in 
the nephrotic syndrome.  Methods: We examined the je-
junal Na + ,K + -ATPase activity and the role of dopamine in 
puromycin aminonucleoside (PAN) and HgCl 2 -induced 
nephrotic syndrome rat models.  Results: In both ne-
phrotic syndrome rat models, the jejunal Na + ,K + -ATPase 
activity was reduced during greatest sodium retention 
and ascites accumulation (PAN nephrosis, day 7; HgCl 2  
nephrosis, day 14), whereas during enhanced sodium 
excretion and ascites mobilization the jejunal Na + ,K + -
ATPase activity was increased in HgCl 2  nephrosis (day 
21) and was similar to controls in PAN nephrosis (day 
14). In both PAN- and HgCl 2 -induced nephrosis, the jeju-
nal aromatic  L -amino acid decarboxylase (AADC) activ-
ity, the enzyme responsible for the synthesis of jejunal 
dopamine, did not differ from controls. In addition, the 
jejunal Na + ,K + -ATPase activity was not sensitive to inhi-
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cell layer  [7, 8] and the highest AADC activity is located 
in the jejunum  [9] , where dopamine activates dopamine 
receptors as a paracrine/autocrine substance  [6] . 
 Although the small intestine is responsible for most of 
the absorption of nutrients, water and electrolytes  [10] , 
under normal circumstances wide variations in salt in-
take are translated into parallel changes in renal salt ex-
cretion, so that the extra-cellular volume is maintained 
within narrow limits  [11] . This suggests that the relative 
importance of the intestinal sodium absorption on the 
control of extracellular volume may assume particular 
relevance when the renal handling of sodium is compro-
mised. Accordingly, wide variations in sodium intake did 
not change the jejunal Na + ,K + -ATPase activity or the je-
junal dopamine production in adult rats with mature and 
well-functioning kidneys whereas during early postnatal 
life when the kidney has a limited capacity to regulate 
fl uid and electrolytes metabolism a high sodium intake 
was accompanied by a decreased jejunal Na + ,K + -ATPase 
activity which was sensitive to inhibition by dopamine 
 [12] . These results suggest the occurrence of complemen-
tary functions between the intestine and the kidney dur-
ing development. Interestingly, it has been recently re-
ported a signifi cant reduction in jejunal Na + ,K + -ATPase 
activity with recovered sensitivity to inhibition by dopa-
mine in rats submitted to uninephrectomy  [13] . This fur-
ther reinforces the view that the infl uence of jejunal 
Na + ,K + -ATPase activity on sodium homeostasis may as-
sume particular importance when the renal function is 
compromised. 
 Nephrotic syndromes may develop in human patients 
as a result of primary diseases as well as in laboratory 
animals in response to toxic substances such as puromy-
cin aminonucleoside (PAN) and mercury chloride (HgCl 2 ) 
 [14] . The features of the nephrotic syndrome in both man 
and experimental rat models are massive proteinuria and 
development of edema and extra-cellular volume expan-
sion secondary to abnormal renal sodium retention. Al-
though the exact mechanisms involved in the enhanced 
sodium reabsorption in the nephrotic syndrome still re-
main to be fully elucidated, most of the available evi-
dences implicate a primary renal sodium handling abnor-
mality in the cortical collecting ducts  [15] . 
 Because the extracellular volume expansion in the ne-
phrotic syndrome is related to disruption of the normal 
renal sodium handling mechanisms, we found it was 
worthwhile to study the jejunal Na + ,K + -ATPase and do-
paminergic activities in both PAN nephrosis and HgCl 2 -
induced membranous nephropathy. 
 Materials and Methods 
 In vivo Studies 
 PAN Nephrosis 
 Normotensive male Sprague-Dawley rats (Harlan, Barcelona, 
Spain), weighing 200–220 g, were selected after a 7-day period of sta-
bilization and adaptation to blood pressure measurements. The ani-
mals received a single intraperitoneal injection of 10 ml    kg BW –1  of 
PAN (150 mg    kg BW –1 ) or the vehicle (NaCl 0.9%) on the day 0. 
 HgCl 2  Nephrosis 
 Normotensive male Brown-Norway rats (Harlan), weighing 
150–160 g, were selected after a 7-day period of stabilization and 
adaptation to blood pressure measurements. The animals received 
subcutaneous injections of 1 ml    kg BW –1  of HgCl 2  (1 mg    kg BW –1 ) 
or the vehicle (NaCl 0.9%) on days 0, 2, 4, 7, 9 and 11. 
 The animals were kept under controlled environmental condi-
tions (12:  12 h light/dark cycle and room temperature 22  8 2  °  C); 
fl uid intake and food consumption were monitored daily through-
out the study. All animals had free access to tap water. The PAN-
treated and HgCl 2 -treated animals were fed ad libitum throughout 
the study with ordinary rat chow (Panlab, Barcelona, Spain) con-
taining 1.9 g    kg –1  of sodium. In order to achieve the same daily 
sodium intake between groups, the vehicle-treated rats had only 
access to the mean daily rat chow intake of the respective nephrot-
ic animals. The rats were kept in metabolic cages (Techniplast, 
Buguggiate, VA, Italy) for the collection of 24-hour urine. Blood 
pressure (systolic and diastolic) was measured weekly throughout 
the study in conscious restrained animals using a photoelectric tail-
cuff pulse detector (LE 5000, Letica, Barcelona, Spain). Four de-
terminations were made each time and the means were used for 
further calculation. On the days of sacrifi ce (PAN, days 7 and 14; 
HgCl 2 , days 7, 14 and 21), the animals were anesthetized with pen-
tobarbital sodium (50 mg    kg BW –1  i.p.). The ascites weight was 
determined through moistening and weighing an absorbent paper. 
Blood was collected from the heart in tubes containing lithium/
heparin for later determination of sodium and creatinine. Segments 
of jejunum with   10 cm in length were removed, opened longitu-
dinally with fi ne scissors and rinsed free from blood and intestinal 
contents with cold saline. One segment was used for the assay of 
Na + ,K + -ATPase activity in jejunal epithelial cells. On a different 
segment, the jejunal mucosa was removed with a scalpel. Fragments 
of jejunal mucosa were used for later determination of AADC ac-
tivity, whereas other fragments weighing around 200 mg were 
placed in vials containing 1 ml of 0.2  M perchloric acid and stored 
at –80  °  C until quantifi cation of catecholamines by HPLC with elec-
trochemical detection. 
 In vitro Studies 
 AADC Activity 
 AADC activity was determined in homogenates of jejunal mu-
cosa, using  L -Dopa (0.1–10 m M ) as substrate  [16, 17] . The assay 
of dopamine was performed by HPLC with electrochemical detec-
tion. The protein content in cell suspension (1.5 mg    ml –1 ) was de-
termined by the method of Bradford  [18] . 
 Na + ,K + -ATPase Activity 
 Na + , K + -ATPase activity was measured by the method of Quig-
ley and Gotterer  [19] adapted in our laboratory with slight modifi -
cation  [20] . The rat jejunal epithelial cells were isolated as described 
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by Vieira-Coelho et al.  [12] . The Na + ,K + -ATPase activity was de-
termined in conditions of saturating sodium and Tris salt adeno-
sine 5  -triphosphate (ATP) concentration. The isolated jejunal 
 epithelial cells were pre-incubated for 10 min at 37  °  C followed 
by rapid freezing at –80  °  C and subsequent thawing to allow cell 
permeabilization. The reaction mixture, in the fi nal volume of 
1.025 ml, contained (in m M ): 37.5 imidazole buffer, 75 NaCl, 5 
KCl, 1 sodium EGTA, 5 MgCl 2 , 75 NaN 3 , 75 tris(hydroxymethyl) 
amino methane(tris) hydrochloride and 100   l cell suspension. For 
determination of ouabain-resistant ATPase, NaCl and KCl were 
omitted, and Tris-HCl (150 m M ) and ouabain (1 m M ) were added 
to the assay. The reaction was initiated by addition of 4 m M ATP 
for all assays except for the determination of the kinetic parameters 
of Na + ,K + -ATPase activity, where increasing concentrations of 
ATP (0.025–4 m M ) were used. After incubation at 37  °  C for 20 min, 
the reaction was terminated by the addition of 50   l of ice-cold 
trichloroacetic acid. The samples were centrifuged (4,000 rpm) and 
liberated P i  in the supernatant was measured as the result of ATPase 
activity. The assay of P i  was performed by spectrophotometry. Oua-
bain-sensitive ATPase activity is expressed as nanomoles of P i  per 
miligram of protein per minute and determined as the difference 
between total and ouabain-resistant ATPase. The protein content 
in cell suspension (1.1 mg    ml –1 ) was determined by the method 
described by Bradford  [18] using bovine serum albumin as stan-
dard. For both Sprague-Dawley and Brown-Norway rat strains, the 
relationship between the incubation time and Na + ,K + -ATPase ac-
tivity was linear between 5 and 40 min. In addition, the relationship 
between protein content in cell suspension and Na + ,K + -ATPase 
activity was linear between 0.4 and 1.3 mg    ml –1 . 
 Assay of Catecholamines 
 The assays of dopamine and  L -Dopa in urine, norepinephrine 
in jejunal mucosa and dopamine in samples from AADC studies 
were performed by HPLC with electrochemical detection, as previ-
ously described  [21] . In our laboratory, the lower limit of detection 
of dopamine ranged from 350 to 1,000 fmol. 
 Plasma and Urine Ionogram and Biochemistry 
 Ion-selective electrodes performed the quantifi cations of sodi-
um. Creatinine was measured by the Jaffé method. Total proteins 
were determined by a colorimetric test, the biuret reaction. The as-
says were performed through Cobas Mira Plus analyser (ABX Di-
agnostics, Switzerland). Creatinine clearance was calculated using 
24-hour urine creatinine excretion. Fractional excretion of sodium 
(FE Na+ ) was calculated as previously reported  [16] . Sodium balance 
was determined subtracting the absolute daily urinary sodium ex-
cretion (mmol    24 h –1 ) to daily sodium intake (mmol    24 h –1 ).  
 Drugs 
 The compounds ATP; dopamine hydrochloride; HgCl 2 ;  L -Dopa; 
ouabain and PAN were obtained from Sigma (St. Louis, Mo., USA). 
 Statistics 
 Results are means  8 SE of values for the indicated number of 
determinations. Maximal velocity (V max ) and Michaelis-Menten 
coeffi cient (K m ) for AADC and Na + ,K + -ATPase enzymatic assay 
were calculated from nonlinear regression analysis using GraphPad 
Prism statistics software package  [22] and compared by one-way 
ANOVA followed by Student’s t test for unpaired comparisons. 
p   ! 0.05 was assumed to denote a signifi cant difference. 
 Results 
 PAN Nephrosis 
 The PAN-treated rats developed severe proteinuria on 
day 4 and beyond reaching a plateau on day 8, whereas 
the renal protein excretion was minimal in control ani-
mals throughout the study ( fi g. 1 ). In parallel, the PAN-
treated rats showed a marked decrease in urinary sodium 
excretion compared with control animals from days 2 to 
8, followed by an increase in the urinary excretion of so-
dium from days 12 to 14 ( fi g. 1 ). On day 7, the PAN-
treated rats exhibited a positive sodium balance and a 
reduced FE Na+  accompanied by marked ascites accumu-
lation, whereas on day 14 the PAN-treated rats presented 
a negative sodium balance and an increased FE Na+  ac-
companied by ascites of much smaller magnitude ( table 
1 ). The creatinine clearance was lower in PAN-treated 
than in control rats either on day 7 or on day 14 ( table 1 ). 
Mean arterial pressure (MAP) did not differ between 
PAN-treated and control rats throughout the study (in 
mm Hg, day 7, 110  8 8 vs. 123  8 8, day 14, 107  8 6 vs. 
103  8 3). 
 The jejunal Na + ,K + -ATPase and dopaminergic 
 activities were evaluated in PAN-treated rats in condi-
tions of greatest sodium retention and ascites accumu-
lation (day 7), as well as during enhanced sodium ex-
cretion and negative sodium balance (day 14) ( fi g. 1 ; 
 table 1 ). 
 The kinetic parameters of Na + ,K + -ATPase activity in 
jejunal epithelial cells from Sprague-Dawley rats in basal 
conditions were: V max , 210  8 23 nmol P i     mg prot –1    
min –1  and K m , 1.2  8 0.4 m M . In experiments performed 
at V max  conditions, the Na + ,K + -ATPase activity in the 
jejunal epithelial cells from PAN-treated rats was reduced 
on day 7 the but not on day 14 ( fi g. 2 ). 
 The activity of AADC in homogenates of jejunal 
 mucosa from PAN-treated and control rats is depicted 
in  table 2 . As can be observed, the V max  and K m  values 
for AADC activity in the jejunal mucosa did not differ 
between PAN-treated and control rats, either on day 7 
or day 14 ( table 2 ). In addition, dopamine (1   M ) did 
not change the jejunal Na + ,K + -ATPase activity in either 
PAN-treated or control rats on days 7 and 14 ( table 3 ). 
 In PAN-treated rats the urinary levels of dopamine 
were signifi cantly reduced on days 7 and 14 ( table 4 ). By 
contrast, the urinary excretion of the dopamine precur-
sor,  L -Dopa, did not differ between PAN-treated and 
control animals ( table 4 ). This resulted in markedly re-
duced urinary dopamine/ L -Dopa ratios in PAN-treated 
rats throughout the study ( table 4 ). 
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 Fig. 1. Urinary excretion of proteins and 
sodium in PAN and  control rats throughout 
the study. Symbols represent means of 12 
rats per group and error bars represent SE. 
* p  ! 0.05, ** p  ! 0.01, *** p  ! 0.001, sig-
nifi cantly different from values in control 
rats. 
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 Fig. 2. Na + ,K + -ATPase activity in isolated 
jejunal epithelial cells from PAN-treated 
and control rats 7 and 14 days after injec-
tion, expressed as the rate of P i  release. Bars 
represent means of 4–7 experiments per 
group and error bars represent SE. * p  ! 
0.05, signifi cantly different from values 
from corresponding control rats. 
Day 7 Day 14
control PAN control PAN
Body weight, g – 22185 24884* 24182 – 23485
Ccr, ml  min–1 –5.6581.38 2.2480.81* 4.5181.08 –2.2480.32*
Na+ balance, mmol  24 h–1 –0.0380.07 0.9080.07* 0.1880.13 –0.6180.38*
FENa+, % –0.1480.01 0.0480.01* 0.1780.03 –0.5380.14*
Ascites, g – 0.780.1 14.581.1* 0.680.1 – 1.380.3*
Values are means 8 SE; n = 5–10 experiments per group. * p < 0.05, signifi cantly dif-
ferent from corresponding values in control rats.
 
 Table 1. Body weight, creatinine clearance 
(C cr ), sodium balance, fractional excretion 
of sodium (FE Na+ ) and ascites weight in 
PAN-treated and control rats on days 7 
and 14 after injection 
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 The tissue levels of norepinephrine in the jejunal mu-
cosa were increased in PAN-treated rats on day 7, where-
as on day 14 the jejunal tissue levels of norepinephrine 
were similar between PAN-treated and control rats ( ta-
ble 5 ). 
 HgCl 2  Nephrosis 
 In HgCl 2 -treated rats, the proteinuria remained unde-
tectable or very low until day 9 and increased from day 11 
and beyond reaching the highest levels between days 15 
and 17 ( fi g. 3 ). The urinary sodium excretion was decreased 
in HgCl 2 -treated rats compared with control animals from 
days 3 to 14 followed by an increase in urinary sodium 
excretion from days 17 to 21 ( fi g. 3 ). Consequently, the 
HgCl 2 -treated rats presented a positive sodium balance on 
both days 7 and 14, this being statistically signifi cant on 
Day 7 Day 14
control PAN control PAN
Vmax, nmol  mg prot–1  15 min–1 105810 105824 10385 83811
Km, mM 2.580.1 2.280.2 2.980.2 2.580.3
Values are means 8 SE; n = 8–10 experiments per group.
 
 Table 2. Kinetic parameters (V max  and 
K m ) of AADC activities in homogenates 
of jejunal mucosa from PAN-treated and 
control rats on days 7 and 14 after 
 injection 
Day 7 Day 14
control PAN control PAN
Basal 10086 100813 10088 100810
Dopamine 1 M 9384 100815 9886 9485
Values are means 8 SE; n = 4–7 experiments per group. Na+,K+-ATPase activity is 
expressed as percentage of control.
 
Day 7 Day 14
control PAN control PAN
Dopamine, nmol  24 h–1 11.180.9  4.780.4* 14.580.6 5.780.7*
L-Dopa, nmol  24 h–1 0.5480.11 0.7380.09 0.7380.23 0.7780.29
Dopamine/L-Dopa 30.788.1  6.780.5* 27.488.4 12.785.9*
Values are means 8 SE; n = 4–8 experiments per group. * p < 0.05, signifi cantly dif-
ferent from corresponding values in control rats.
 
 Table 4. Urinary dopamine,  L -Dopa and 
urinary dopamine/ L -Dopa ratios in PAN-
treated and control rats 7 and 14 days 
 after injection 
 Table 3. Effect of dopamine on Na + ,K + -
ATPase activity in jejunal epithelial cells 
from PAN-treated and control rats on 
days 7 and 14 after injection 
 Table 5. Norepinephrine tissue levels in jejunal mucosa from PAN-
treated and HgCl 2 -treated rats and respective control rats 7, 14 and 
21 days after injection 
Day 7 Day 14 Day 21
Control 327872 290854 –
PAN 7508175* 302854 –
Control 148814 160834 150834
HgCl2 127825 136829 92828
Values are means 8 SE; n = 4–6 experiments per group, values 
are expressed in pmol/g. * p < 0.05, signifi cantly different from cor-
responding values in control rats.
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day 14 when the HgCl 2 -treated rats exhibited a reduced 
FE Na+  and greatest ascites accumulation ( table 6 ). On day 
21, the HgCl 2 -treated rats presented a negative sodium 
balance and ascites mobilization ( table 6 ). The creatinine 
clearance did not differ between HgCl 2 -treated and con-
trol rats on days 7, 14 or 21 ( table 6 ). MAP did not differ 
between HgCl 2 -treated and control rats throughout the 
study (in mm Hg; day 7, 87  8 3 vs. 93  8 6, day 14, 76 
 8 7 vs. 85  8 1, day 21, 104  8 10 vs. 90  8 2). 
 Based on these fi ndings the jejunal Na + ,K + -ATPase 
and dopaminergic activities were evaluated in HgCl 2 -
treated rats in conditions of sodium retention and negli-
gible proteinuria (day 7), during greatest sodium reten-
tion and increased proteinuria (day 14) as well as during 
enhanced sodium excretion and negative sodium balance 
(day 21) ( fi g. 3 ;  table 6 ). 
 The kinetic parameters of Na + ,K + -ATPase activity in 
jejunal epithelial cells from Brown-Norway rats in basal 
condition were: V max , 98  8 16 nmol P i     mg prot –1     min –1  
and K m , 0.33  8 0.10 m M . The Na + , K + -ATPase activity 
in the jejunal epithelial cells from HgCl 2 -treated and con-
trol rats is depicted in  fi gure 4 at V max  condition. As can 
be observed, during the phase of sodium retention the 
HgCl 2 -treated rats presented a reduced jejunal Na + ,K + -
ATPase activity on day 14 but not on day 7 ( fi g. 4 ), where-
as during the phase of sodium excretion the jejunal 
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 Fig. 3. Urinary excretion of proteins and 
sodium in HgCl 2  and control rats through-
out the study. Symbols represent means of 
5–13 rats per group and error bars represent 
SE. * p  ! 0.05, ** p  ! 0.01, *** p  ! 0.001, 
signifi cantly different from values in con-
trol rats. 
 Table 6. Body weight, creatinine clearance (C cr ), sodium balance, fractional excretion of sodium (FE Na+ ) and as-
cites weight in HgCl 2 -treated and control rats on days 7, 14 and 21 after fi rst injection 
Day 7 Day 14 Day 21
control HgCl2 control HgCl2 control HgCl2
Body weight, g 17683  18282 18483 18486 19284 – 15384*
Ccr, ml  min–1 1.1680.08 1.0480.10 1.6180.22 1.6880.15 1.9680.16 ̄1.8180.17
Na+ balance, mmol  24 h–1 0.2580.04 0.4180.06 0.0480.06 0.5080.08* 0.1680.08 ̄0.7680.48*
FENa+, % 0.3980.03 0.3380.03 0.3080.05 0.1680.02* 0.2880.03 ̄0.2680.03
Ascites, g 0.580.1  1.280.1* 0.480.1 1.680.2* 0.880.1 ̄ 0.680.1
Values are means 8 SE; n = 5–10 experiments per group. * p < 0.05, signifi cantly different from correspond-
ing values in control rats.
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Na + ,K + -ATPase activity was markedly increased in 
HgCl 2 -treated animals on day 21 ( fi g. 4 ). 
 The activity of AADC in homogenates of jejunal mu-
cosa from HgCl 2 -treated and control rats is depicted in 
 table 7 . As can be observed, the V max  and K m  values for 
AADC activity in the jejunal mucosa did not differ be-
tween HgCl 2 -treated and control rats on days 7, 14 or 21 
( table 7 ). In addition, dopamine (1   M ) did not change 
the Na + ,K + -ATPase activity in jejunal epithelial cells 
from both HgCl 2 -treated and control rats throughout the 
study ( table 8 ). 
 In HgCl 2 -treated rats the urinary levels of dopamine 
were signifi cantly decreased on days 7, 14 and 21 ( table 
9 ). By contrast, the urinary excretion of the dopamine 
precursor,  L -Dopa, was increased in HgCl 2 -treated ani-
mals throughout the study ( table 9 ). This resulted in 
markedly reduced urinary dopamine/ L -Dopa ratios in 
HgCl 2 -treated rats throughout the study ( table 9 ). 
 The tissue levels of norepinephrine were similar be-
tween HgCl 2 -treated and control rats on days 7, 14 and 
21 after surgery ( table 5 ). 
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 Fig. 4. Na + ,K + -ATPase activity in isolated jejunal epithelial cells 
from HgCl 2 -treated and control rats 7, 14 and 21 days after fi rst 
injection, expressed as the rate of P i  release. Bars represent means 
of 4–7 experiments per group and error bars represent SE. * p  ! 0.05, 
signifi cantly different from values from corresponding control rats. 
 Table 7. Kinetic parameters (V max  and K m ) of AADC activities in homogenates of jejunal mucosa from HgCl 2 -
treated and control rats on days 7, 14 and 21 after fi rst injection 
Day 7 Day 14 Day 21
control HgCl2 control HgCl2 control HgCl2
Vmax, pmol  mg prot–1  15 min–1 125826 126819 191820 170820 191835 212834
Km, mM 3.180.2  4.080.5 3.880.3 3.380.4 3.480.5 3.080.5
Values are means 8 SE; n = 6–10 experiments per group.
 
Day 7 Day 14 Day 21
control HgCl2 control HgCl2 control HgCl2
Basal 10089 10089 100815 100816 10087 10088
Dopamine 1 M 99810 9789 90815 90817 9788 9688
Values are means 8 SE; n = 5–9 experiments per group. Na+,K+-ATPase activity is expressed as percentage 
of control.
 
 Table 8. Effect of dopamine on Na + ,K + -ATPase activity in jejunal epithelial cells from HgCl 2 -treated and control 
rats on days 7, 14 and 21 after fi rst injection 
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 Discussion 
 The present study was undertaken with the aim of clar-
ifying the possible role of the jejunal Na + ,K + -ATPase and 
dopaminergic activities in the control of sodium homeo-
stasis in both PAN- and HgCl 2 -induced nephrosis. We 
found a decreased jejunal Na + ,K + -ATPase activity in 
both nephrotic syndrome rat models during the period of 
greatest sodium retention and ascites accumulation and 
an increased jejunal Na + ,K + -ATPase activity in HgCl 2  
nephrosis during the period of enhanced sodium excretion 
and ascites mobilization. However, the jejunal dopaminer-
gic activity was not altered in either PAN or HgCl 2 -induced 
nephrosis and dopamine was unable to modulate jejunal 
Na + ,K + -ATPase activity in both nephrotic syndrome rat 
models. Taken together, our results suggest that in the ne-
phrotic syndrome the jejunal Na + ,K + -ATPase activity may 
respond in a compensatory way to changes in extracellular 
volume by dopamine-independent mechanisms. 
 PAN is a toxic substance that induces a nephrotic syn-
drome without glomerular infl ammatory lesions or Ig de-
posits  [23] , whereas HgCl 2  induces a systemic autoim-
mune disease that includes membranous nephropathy 
with IgG deposits  [24] . These drug-induced nephropa-
thies develop high-range proteinuria and full-blown ne-
phrotic syndrome  [14] . Because the time courses of uri-
nary sodium excretion and the relationship between ex-
cretion of proteinuria and ascites differed in these two 
nephrotic syndrome rat models we performed a system-
atic study of the time courses of these parameters and 
evaluated the jejunal Na + ,K + -ATPase and dopaminergic 
activities in both PAN and HgCl 2  nephrosis in different 
temporal conditions including: (1) negligible proteinuria 
accompanied by signifi cant sodium retention (HgCl 2  ne-
phrosis, day 7); (2) increased proteinuria accompanied by 
greatest sodium retention and ascites accumulation (PAN 
nephrosis, day 7; HgCl 2  nephrosis, day 14), and (3) in-
creased proteinuria accompanied by enhanced renal so-
dium excretion and ascites mobilization (PAN nephrosis, 
day 14; HgCl 2  nephrosis, day 21). 
 Interestingly, we found in the two nephrotic syndrome 
rat models that in the presence of increased proteinuria, 
the jejunal Na + ,K + -ATPase activity was reduced during 
the phase of greatest sodium retention and positive so-
dium balance but not during enhanced sodium excretion 
and ascites mobilization. Because the driving force that 
energizes all mechanisms of jejunal sodium absorption is 
the hydrolysis of ATP catalyzed by Na + ,K + -ATPase lo-
cated at the basolateral membrane of intestinal epithelial 
cells  [25] , these fi ndings provide evidence for a decreased 
jejunal sodium absorption in the nephrotic syndrome 
when the extracellular volume is expanded due to abnor-
mal renal sodium retention. Our results fi t well with the 
previous fi ndings suggesting that extracellular volume ex-
pansion with isotonic saline, 5% albumin or during as-
citic cirrhosis may be accompanied by decreases in jeju-
nal ion and fl uid absorption  [26–32] . The fi nding of re-
duced Na + ,K + -ATPase activity in jejunal epithelial cells 
during greatest sodium retention in both nephrotic syn-
drome rat models, involving different toxic agents and 
different histologic types of glomerular lesions, suggests 
that the modulation of jejunal sodium absorption may 
take place in response to changes in sodium metabolism 
in other nephrotic syndrome conditions, including mini-
mal change disease and membranous nephropathy in hu-
man patients. 
 The phase of sodium retention with negligible protein-
uria was only observed in HgCl 2 -treated rats because in 
PAN nephrosis proteinuria was always profuse. We found 
in HgCl 2 -treated rats that the jejunal Na + ,K + -ATPase ac-
 Table 9. Urinary dopamine,  L -Dopa and urinary dopamine/ L -Dopa ratios in HgCl 2 -treated and control rats on 
days 7, 14 and 21 after fi rst injection 
Day 7 Day 14 Day 21
control HgCl2 control HgCl2 control HgCl2
Dopamine, nmol  24 h–1 11.881.4 8.680.6* 11.081.3 7.481.5* 9.581.5 5.181.6*
L-Dopa, nmol  24 h–1 0.4780.16 2.2380.82* 0.2080.04 0.7780.17* 0.3280.07 0.8080.45
Dopamine/L-Dopa 32.087.0 6.4481.0* 63.0810.7 12.883.6* 35.589.6 14.086.1*
Values are means 8 SE; n = 5–13 experiments per group. * p < 0.05, signifi cantly different from correspond-
ing values in control rats.
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tivity on day 7 did not differ from controls. Given that in 
all experimental models of nephrotic syndrome, the ex-
pansion of extra-cellular volume and formation of ascites 
requires the association of proteinuria and marked de-
crease in urinary sodium excretion  [14] , one can speculate 
that on day 7 the HgCl 2 -treated rats were not suffi ciently 
volume expanded to induce a jejunal response. 
 During the phase of increased renal sodium excretion 
and ascites mobilization, the jejunal Na + ,K + -ATPase activ-
ity was found to be signifi cantly increased in HgCl 2 -treated 
but not in PAN-treated rats. Because the HgCl 2 -treated rats 
exhibited a negative sodium balance going along with a de-
crease in body weight, one can hypothesize that the en-
hanced jejunal Na + ,K + -ATPase activity on day 21 may 
have resulted from the decrease in extracellular volume. In 
agreement with this view are the results showing that the 
decrease in extracellular volume following sodium deple-
tion, dehydration and hemorrhage is associated with a sub-
stantial increase in the rate of ion and water absorption 
from small intestine  [33–36] . The fi nding that the jejunal 
Na + ,K + -ATPase activity on day 14 was similar between 
PAN-treated and control rats may be explained on the ba-
sis that the negative sodium balance in PAN-treated rats 
was not accompanied by a decrease in the extracellular vol-
ume. In agreement with this view is the similar body weight 
between PAN-treated and control rats as well as the pres-
ence of residual ascites in PAN-treated rats on day 14. 
 The use of drug-induced nephrotic syndrome rat mod-
els could be associated with direct toxicity of both PAN 
and Hg on jejunal epithelial cells as well as on Na + ,K + -
ATPase activity. However, a previous study on the jeju-
nal transport in PAN-induced nephrotic syndrome sug-
gested that the decrease in the intestinal absorption of 
glucose, phenylalanine, histidine, water and sodium is 
not related to acute PAN toxicity being instead associ-
ated with the metabolic consequences of the nephrotic 
syndrome  [37] . Although Hg is known to induce toxic ef-
fects in different body organs and cellular components 
including jejunal epithelial cells  [38, 39] , limited or non 
existing data is available regarding the jejunal Na + ,K + -
ATPase. In jejunum, Hg was associated with inhibition 
of amino acid and sugar transport  [40–42] and the sites 
of Hg action were suggested to be located in the mucosal 
surface of jejunal slices but not in the basolateral cell bor-
der  [43] . The results of the present study in HgCl 2 -treated 
rats showing that the jejunal Na + ,K + -ATPase activity 
changed from normal to low and to high values in paral-
lel with changes in sodium balance further suggest that in 
jejunal epithelial cells the basolateral Na + ,K + -ATPase 
may escape Hg toxicity. 
 At the intestinal level, previous studies have shown 
that the inhibitory effects of dopamine on jejunal sodium 
absorption and Na + ,K + -ATPase activity in rat jejunal ep-
ithelial cells are limited to animals under 20 days of age, 
adult animals being insensitive to the inhibitory effects 
of dopamine  [6, 12, 44] . Intestinal function has a great 
impact during early postnatal life, not only on the uptake 
of nutrients but also on the maintenance of electrolytes 
and water metabolism  [45, 46] . In fact, although nephro-
genesis is complete at birth, renal tubular function con-
tinues to develop postnatally, and the kidney has a lim-
ited capacity to regulate fl uids and electrolyte homeosta-
sis  [47] . The lack of effect of dopamine on jejunal 
Na + ,K + -ATPase activity in adult animal coincided with 
the period in which renal function has reached matura-
tion  [12, 44] . Recently, a reduction in jejunal Na + ,K + -
ATPase activity with recovered sensitivity to inhibition 
by dopamine was reported in rats submitted to unine-
phrectomy presenting an enhanced dopamine synthesis 
per nephron  [13] . This further suggested the occurrence 
of complementary functions between the intestine and 
the kidney with dopaminergic system playing a role in 
renal-intestinal cross-talk. In the present study, the jeju-
nal AADC activity was not altered in both nephrotic syn-
drome rat models and the jejunal Na + ,K + -ATPase activ-
ity was not sensitive to inhibition by dopamine through-
out the study. This was accompanied in both nephrotic 
syndrome rat models by a decreased renal dopamine syn-
thesis as evidenced by a reduced urinary dopamine excre-
tion accompanied by decreased urinary dopamine/ L -
Dopa ratios throughout the study. Since the urinary 
dopamine/ L -Dopa ratios are used as rough measure of 
tubular uptake and/or decarboxylation of  L -Dopa to do-
pamine, our fi ndings suggest that the decreases in urinary 
dopamine excretion observed in both nephrotic syn-
drome rat models are related to a reduced tubular uptake/
decarboxylation of  L -Dopa to dopamine. In addition, the 
PAN-treated rats presented a decreased creatinine clear-
ance suggesting that a reduced number of well function-
ing tubular units may also contribute to the decrease in 
urine dopamine excretion in PAN-treated but not in 
HgCl 2 -treated animals. Taken together, our results sug-
gest that in either PAN- or HgCl 2 -induced nephrosis the 
observed changes in jejunal Na + ,K + -ATPase activity are 
mediated by dopamine-independent mechanisms despite 
the decreased renal dopaminergic activity and do not sup-
port the existence of dopamine-mediated complementary 
functions in sodium transport between the kidney and the 
intestine, in the nephrotic syndrome. 
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 Since our results were negative in terms of the role of 
dopaminergic system in the jejunum, one can hypothe-
size that other mechanisms involved in sodium transport 
can account for the changes in jejunal Na + ,K + -ATPase in 
the nephrotic syndrome. The changes observed in jejunal 
Na + ,K + -ATPase in both nephrotic syndrome rat models 
could be infl uenced by blood pressure values. However, 
no signifi cant changes were observed in MAP in either 
PAN or HgCl 2  nephrosis. Norepinephrine is well-recog-
nized to stimulate sodium transport by increasing the je-
junal Na + ,K + -ATPase activity. However, the jejunal tis-
sue levels of norepinephrine did not differ between the 
nephrotic and control rats throughout the study with the 
exception of PAN-treated rats on day 7 where a decreased 
jejunal Na + ,K + -ATPase activity was accompanied by in-
creased jejunal tissue levels of norepinephrine. Thus one 
can conclude that, similarly to dopamine, jejunal norepi-
nephrine cannot account for the observed changes in je-
junal Na + ,K + -ATPase activity in both nephrotic syn-
drome rat models. Other mediator mechanisms can mod-
ulate the intestinal sodium transport in response to 
changes in extracellular volume and deserve further study 
in a state of proteinuria. Evidence has been gathered 
showing that ANP reduces fl uid absorption in response 
to acute volume expansion  [29] , whereas both angioten-
sin II and angiotensin III can enhance intestinal electro-
lyte and fl uid absorption in response to volume depletion 
 [35] . In addition, angiotensin II was shown to modulate 
the intestinal Na + ,K + -ATPase activity via calcium mobi-
lization and PKC activation  [48] . In acute renal failure, 
an increase in serum aldosterone was suggested to stimu-
late the jejunal Na + ,K + -ATPase activity  [49] , whereas 
5-hydroxytryptamine was found to increase Na + ,K + -
ATPase activity in jejunal epithelial cells from young rats 
 [50] . On the other hand, NO donor (s-nitroso-n-acetyl-
penicillamine) was shown to inhibit Na + ,K + -ATPase 
 activity in an intestinal cell line (IEC-6)  [51] . 
 It is concluded that in the nephrotic syndrome the je-
junal Na + ,K + -ATPase activity appears to respond in a 
compensatory way to changes in extracellular volume by 
dopamine-independent mechanisms. 
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